The Neurodegenerative Diseases (TAU protein, Phospho-TAU protein, Amyloid Peptide) test is performed to measure biomarkers related to neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and other neurological disorders. These markers play a crucial role in the early detection, diagnosis, and monitoring of the progression of these neurological conditions.